⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Castle Biosciences, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Castle Biosciences, Inc.
↗Friendswood, USA
Castle Biosciences is a commercial-stage molecular diagnostics company focused on providing physicians and their patients with personalized, clinically actionable genomic information to guide treatment decisions. The company specializes in dermatologic and gastroenterological diseases, offering a portfolio of proprietary gene expression profile (GEP) tests.
Founded in 2008, the company operates CLIA-certified, CAP-accredited laboratories in Phoenix, Arizona, and Pittsburgh, Pennsylvania, with headquarters in Friendswood, Texas. Its core products include DecisionDx-Melanoma, TissueCypher Barrett's Esophagus test, and DecisionDx-SCC, which are designed to improve patient outcomes by addressing unmet clinical needs in disease management.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$345M-$355M
Founded:2008
Ownership:public
Status:operating
STOCK
Exchange:NASDAQ
Ticker:CSTL
Market Cap:$0.72B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Molecular Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:SciBase (Collaboration and License Agreement for dermatological diagnostic tests)
COMPETITION
Position:Leader
Competitors:Exagen, SkinCure Oncology, Various dermatopathology and diagnostic labs
LEADERSHIP
Key Executives:
Derek J. Maetzold - Founder, President and CEO
Frank Stokes - Chief Financial Officer
Kristen Oelschlager - Chief Operating Officer
Scientific Founders:Derek J. Maetzold
LINKS
Website:castlebiosciences.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Castle Biosciences, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.